What's breaking now, across thousands of outlets.
Vertex Pharmaceuticals reported that an experimental kidney disease drug called inaxaplin improved measures on a urine test in two different patient populations, raising optimism ahead of the company’s upcoming pivotal readout. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- A collection of rare infections passed from mothers to fetuses raised the risk of autism or intellectual disability in offspring, according to a Swedish population-based cohort…
A new study identified more than 1 million people taking weight-loss drugs without any apparent medical reason to do so.
Site clearing has begun at the Korle Bu Teaching Hospital for the construction of a new 400-bed maternity block to expand and modernise maternal and neonatal healthcare services.
The collaboration between Syngene and Bristol Myers Squibb began in 1998, culminating in the establishment of the Biocon Bristol Myers Squibb Research and Development Center, Syngene's first dedicated…
The Trump administration plans to remove hundreds of thousands of people from Obamacare rolls over alleged improper enrollment, while suspending brokers.
